×
News Home

Should Medical Devices Stock Insulet Corporation (PODD) Be in Your Portfolio Friday?

Friday, January 14, 2022 11:53 AM | InvestorsObserver Analysts
Should Medical Devices Stock Insulet Corporation (PODD) Be in Your Portfolio Friday?

The 23 rating InvestorsObserver gives to Insulet Corporation (PODD) stock puts it near the bottom of the Medical Devices industry. In addition to scoring higher than 15 percent of stocks in the Medical Devices industry, PODD’s 23 overall rating means the stock scores better than 23 percent of all stocks.

Overall Score - 23
PODD has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on PODD!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 23 means the stock is more attractive than 23 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Insulet Corporation Stock Today?

Insulet Corporation (PODD) stock is trading at $238.37 as of 11:52 AM on Friday, Jan 14, a drop of -$4.00, or -1.65% from the previous closing price of $242.37. The stock has traded between $236.33 and $240.96 so far today. Volume today is below average. So far 367,817 shares have traded compared to average volume of 501,182 shares. Click Here to get the full Stock Report for Insulet Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App